Case Studies

Each case study showcases how we deliver impactful, tailored solutions.

Get in touch

Rapid initiation and agile delivery of a complex Phase I COVID vaccine study

This successful trial was completed when the milestone of database lock was achieved just four weeks after last patient last visit.

Clinical Research
uk Biotech

Global real-world evidence (RWE) pilot study in antimicrobial resistance (AMR)

8,060 hospitalised patient records were submitted — 7,444 (92%) were complete enough to include in the final analysis.

Real World Evidence
top 10 Pharma

Open-access portal for a global antimicrobial resistance (AMR) surveillance programme

8+ million records across 900,000+ clinical isolates — searchable by pathogen, antimicrobial, demographics, phenotype and genotype.

AMR Surveillance
top 10 Pharma

Accelerating patient recruitment in a specialised anti-infective therapy area

Within the first month of Micron starting the study, monthly patient recruitment attained the target.

Clinical Research
pharma

Phase IIb/c trial of a novel anti-tuberculosis oral regimen completed within one year

Recruitment of patients with tuberculosis can be challenging, and retaining participation of the full quota of 122 patients to assess response to treatment was crucial to the trial’s success.

Clinical Research
pharma

Let's build a partnership!

Get in touch

Our Offices

Micron Research

109B Lancaster Way Business Park

CB6 3NX, Ely, Cambridgeshire

England, United Kingdom

US Micron

12022 Blue Valley Parkway, Overland Park

Kansas 66213, United States of America

Clindev

5 Regency Drive, Building C, Route 21 Corporate Park Irene, South Africa

EU Micron

Harju maakond, Tallinn, Kesklinna linnaosa

Viru väljak 2, Tallinn 10111, Estonia

LogicTrials

9 Regency Drive, Building B, Route 21 Corporate Park

Irene, 0157, South Africa

© The Micron Group 2025